Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

One Pill Makes You Stronger: Pfizer Earnings Bring Strength To Your Portfolio
Seeking Alpha
Wednesday, November 2, 2011 - 11:22am
tags:
earnings, Merck, Pfizer
Endo gets OK for generic of AstraZeneca blood pressure drug
Bizjournals.com
Wednesday, November 2, 2011 - 11:19am
tags:
Qualitest, Plendil, generics, Endo, AstraZeneca, antihypertensives
Sanofi reorganizing research, trimming sales force
Yahoo/AP
Wednesday, November 2, 2011 - 11:15am
tags:
Sanofi, layoffs, sales force, R&D, reorganization
GSK Sets Stage for Big Late-Stage Drug Events, Potential Blockbusters
Motley Fool
Wednesday, November 2, 2011 - 11:14am
tags:
GSK, Relovair, IPX066, Dolutegravir
Teva 3rd-quarter net off 13%, sales up 2.2%
Marketwatch
Wednesday, November 2, 2011 - 11:12am
tags:
Teva Pharmaceuticals, earnings
Lupin Gets U.S. FDA Approval for Tramadol Painkiller Pill
Bloomberg
Wednesday, November 2, 2011 - 11:11am
tags:
Lupin, FDA, Tramadol, painkillers, generics, Ultram, JNJ
Ranking Drug Company Dividend Stocks By Risk And Growth
Seeking Alpha
Tuesday, November 1, 2011 - 6:14pm
tags:
dividends, JNJ, Pfizer, Novartis, GSK, Merck, Sanofi, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly
Neurocrine Looks Well-Positioned For The Future
Seeking Alpha
Tuesday, November 1, 2011 - 6:11pm
tags:
Neurocrine, earnings
Pfizer May Offer Over-the-Counter Lipitor
Bloomberg
Tuesday, November 1, 2011 - 6:10pm
tags:
Pfizer, statins, Lipitor
Sanofi set to rev past Pfizer in pharma rankings
Fierce Pharma
Tuesday, November 1, 2011 - 12:43pm
tags:
Sanofi, Pfizer
CMS: No Idea When We’ll Meet Sunshine Deadline
Pharmalot
Tuesday, November 1, 2011 - 12:23pm
tags:
Physician Payment Sunshine Act, CMS, physicial payments
Eisai First-Half Profit Falls 17% as Aricept Sales Decline
Bloomberg
Tuesday, November 1, 2011 - 12:22pm
tags:
Eisai, earnings
NPS Pharmaceuticals' Selloff Was Overdone
Seeking Alpha
Tuesday, November 1, 2011 - 12:21pm
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Watson Pharma Hikes Outlook; Court Decision Weighs
Investors.com
Tuesday, November 1, 2011 - 12:19pm
tags:
Watson, earnings
4 Pharma Stocks Poised To Get FDA Approval
Seeking Alpha
Tuesday, November 1, 2011 - 11:13am
tags:
JNJ, Eli Lilly, Pfizer
5 One-Drug Wonders Going for No. 2
Motley Fool
Tuesday, November 1, 2011 - 11:09am
tags:
Dendreon, Provenge, DN24-02, Elan, Tysabri, bapineuzumab, ONYX Pharmaceuticals, Bayer, regorafenib, Carfilzomib, Nexavar, Vertex, Merck, Incivek, Kalydeco, Momenta, Lovenox, Copaxone, Teva Pharmaceuticals
Vical: All Systems Are Go
Seeking Alpha
Tuesday, November 1, 2011 - 11:06am
tags:
Vical, earnings
Exelixis clashes with FDA over prostate cancer study, shares tank
Fierce Biotech
Tuesday, November 1, 2011 - 11:05am
tags:
prostate cancer, FDA, Exelixis, cabozantinib
Hyperactivity Drugs Shown Not to Raise Heart Risks in Children
Bloomberg
Tuesday, November 1, 2011 - 11:03am
tags:
ADHD, Shire, Adderall, Novartis, Ritalin, Concerta, JNJ
YM BioSciences' Upcoming CYT387 Catalyst May Be One To Watch
Seeking Alpha
Tuesday, November 1, 2011 - 11:02am
tags:
CYT387, YM BioSciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.